Clinical trial
Hip Viscosupplementation: What is the Best Dosage?
NCT01810809 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hip Viscosupplementation: What is the Best Dosage?
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 30, 2013
- Completion date
- November 30, 2014
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.